GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) » Definitions » Interest Expense

Pharbaco Central Pharmaceutical JSC No 1 (HSTC:PBC) Interest Expense : ₫ Mil (TTM As of . 20)


View and export this data going back to 2019. Start your Free Trial

What is Pharbaco Central Pharmaceutical JSC No 1 Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Pharbaco Central Pharmaceutical JSC No 1's interest expense for the six months ended in . 20 was ₫ 0.00 Mil. Pharbaco Central Pharmaceutical JSC No 1 does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Pharbaco Central Pharmaceutical JSC No 1's Operating Income for the six months ended in . 20 was ₫ 0.00 Mil. Pharbaco Central Pharmaceutical JSC No 1's Interest Expense for the six months ended in . 20 was ₫ 0.00 Mil. Pharbaco Central Pharmaceutical JSC No 1 did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Pharbaco Central Pharmaceutical JSC No 1 Interest Expense Historical Data

The historical data trend for Pharbaco Central Pharmaceutical JSC No 1's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharbaco Central Pharmaceutical JSC No 1 Interest Expense Chart

Pharbaco Central Pharmaceutical JSC No 1 Annual Data
Trend
Interest Expense

Pharbaco Central Pharmaceutical JSC No 1 Semi-Annual Data
Interest Expense

Pharbaco Central Pharmaceutical JSC No 1 Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.


Pharbaco Central Pharmaceutical JSC No 1  (HSTC:PBC) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pharbaco Central Pharmaceutical JSC No 1's Interest Expense for the six months ended in . 20 was ₫0.00 Mil. Its Operating Income for the six months ended in . 20 was ₫0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was ₫0.00 Mil.

Pharbaco Central Pharmaceutical JSC No 1's Interest Coverage for the quarter that ended in . 20 is calculated as

Pharbaco Central Pharmaceutical JSC No 1 had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Pharbaco Central Pharmaceutical JSC No 1 Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
160 Ton Duc Thang, Hang Bot ward, Dong Da District, Hanoi, VNM
Pharbaco Central Pharmaceutical JSC No 1 is a pharmaceutical company. Some of its products include Cefadroxil 250mg, Elnizol infusion drug, and Fabafixim 50.

Pharbaco Central Pharmaceutical JSC No 1 Headlines

No Headlines